Trials / Completed
CompletedNCT03399214
Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects
A Phase Ib Study to Evaluate Safety and Efficacy Profiles of IOP Injection for Magnetic Resonance Imaging (MRI) Contrast Agent in Healthy Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- MegaPro Biomedical Co. Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to assess the dose dependent changes in MRI signal intensity (SI) in liver after IOP Injection intravenous administration in healthy volunteers.
Detailed description
Find the max. signal change after IOP administration
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IOP Injection | T1 and T2 |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2018-05-01
- Completion
- 2018-07-31
- First posted
- 2018-01-16
- Last updated
- 2018-08-17
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03399214. Inclusion in this directory is not an endorsement.